Ra Medical Systems, Inc. Gains 26.4%

Ra Medical Systems, Inc. (RMED:NYSE) shot up at $0.37, a gain of 26.4%. On Wed, Apr 27, 2022, RMED:NYSE touched a New 2-Week Low of $0.3. The stock got featured on our News Catalysts scanner on Tue, Apr 05, 2022 at 09:14 AM in the 'PRIVATE PLACEMENT' category. From Wed, Apr 13, 2022, the stock recorded 22.22% Up Days and 10.00% Green Days

About Ra Medical Systems, Inc. (RMED:NYSE)

Ra Medical Systems Inc is a commercial-stage medical device company. It is engaged in designing, developing, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company's products include DABRA and Pharos. DABRA System is an effective, and versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels, and the Pharos is a monochromatic, xenon-chlorine, 308-nm UVB excimer laser for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Its business segments are the Dermatology segment and the Vascular segment. Generating, its revenue from the Dermatology segment.